Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD
Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Purpose
Evaluation of three aflibercept injections at 4-week intervals in patients with neovascular AMD showing an “insufficient anatomic response” to prior anti-VEGF therapy with ranibizumab or bevacizumab.
Methods
The retrospective analysis included 96 eyes that had received at least three intravitreal 0.5 mg ranibizumab or 1.25 mg bevac...
Alternative Titles
Full title
Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4218980
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4218980
Other Identifiers
ISSN
0721-832X,1435-702X
E-ISSN
1435-702X
DOI
10.1007/s00417-014-2589-3
